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INTRODUCTION
It has been previously suggested that cell-mediated immunologic responses in patients with diabetes levels of glucose, as determined by the glucose oxidase method (15) in db+/db+ mice ranged from 315 to 656 mg/dl as compared with 130-190 mg/dl for db+/m+ and m+/m+ mice. CBA/H (H-2k), and C57BL/6 (H-2b) mice were obtained from the University of Minnesota Mouse Colony. Mice were kept in plastic cages with Purina Laboratory Chow (Ralston Purina Co., St. Louis, Mo.) and water ad lib.
and mnaintained under standard conditions with 12 h of light (6 a.m.-6 p.m.) and 12 h of darkness (6 p.m.-6 a.m.). To minimize any circadian influence on immune response (16) both immunization and killing of animals was carried out strictly' between 9 and 10 a.m.
Tumor cells. EL-4 lymphoma cells (IJ-2b) (17) were maintained by weekly serial intraperitoneal injection of EL-4 cells into syngeneic C57BL/6 hosts. LSTRA lymphoma cells (H-2d) (17) were maintained by serial intraperitoneal injection of LSTRA cells into syngeneic BIALB/c hosts.
Mitogen stimulation. Details of this assay have been described previously (18) . Nucleated spleen cells (5 x 105) from individual mice were cultured in 0.2 ml of RPMI-1640 medium containing 2% heat-inactivated (56°C, 45 min) fetal calf serum (FCS),' penicillin, streptomycin, and glutamine ( Mixed lymphocyte reaction. Mixed lymphocyte reactions were performed by slight modification of the procedure described by Fathman et al. (19) . Briefly, spleen cell cultures were prepared in RPMI-1640 medium containing 5% FCS, streptomycin, penicillin, and glutamine. Stimulator cells were treated with 25 .g/ml mitomycin C (Sigma Chemical Co.) for 30 (23) .
Allogeneic skin grafts. Grafting of full thickness skin grafts was performed as previously described (25) . The grafts were examined daily and the interpretation of rejection was based upon the gross observation of skin hemorrhage in 50% of the grafted skin.
In vivo assay of DNA synthesis in spleen and thymus. 
RESULTS
Stimulation of lymphocytes by mitogens. No significant differences were observed in the mean response of spleen cells from db+/db+, db+/rn+, or m+/m+ mice to stimulation with PHA, Con A or LPS after 40, 64, 88, or 112 h ofculture. Fig. 1 illustrates the response to optimal concentrations of PHA (1 fug/ml), Con A (2.5 ,ug/ml), and LPS (100 ,ug/ml) after 64 h of culture (time of maximal response). The range of responses of diabetic mice of PHA and Con A was somewhat greater than the range of responses of nondiabetic mice.
Mixed lymphocyte reaction. Table I shows the mean proliferative response (as measured by stimulation index) of db+/db+, db+/m+, and m+/m+ (all H-2d) spleen cells to allogeneic stimulation by C57BL/6 (H.-2b) and CBA/H (H-2k) spleen cells. The mean stimulation indices of db+/db+ spleen cells to stimulation by C57BL/6 and CBA/H alloantigens was diminished when compared to the mean responses of. db+/m+ or m+/m+ mice but the differences were not statistically significant (P > 0.05).
Response to immunization with SRBC. The PFC response of spleen cells from 2-to 6-mo-old db+/db+ mice was significantly increased (1.4-to 3.0-fold, P <0.05) compared with the response of spleen cells (Table III) . (Table IV, exps. III and IV). The cytotoxic response of db+/db+ spleen cells was also diminished when compared to db+/m+ or m+/m+ mice in 3-and 9-h cytotoxicity assays and was also found to be depressed when compared to db+/m+ mice after immunization with an increased dose (10 x 106) of EL-4 cells (data not shown). The latter results indicated that the cytotoxic deficiency in db+/ db+ mice is not due to a low immunogenic dose of tumor cells.
In contrast with these findings, when spleen cells from db+/db+, db+/m+, m+/m+, and C57BL/Ks (all H-2d) mice were sensitized in vitro to spleen cells from C57BL/6 (H-2b) mice only minor differences were noted in cytolytic activity against 5tCr-labeled EL-4 (H-2b) cells (Table V) . Spleen cells from all diabetic and nondiabetic mice generated high levels of cytotoxicity. The cytotoxicity generated was specific; 5'Cr-labeled LSTRA (H-2d) lymphoma cells were not lysed (data not shown). The cytolytic activity of spleen cells from four of five db+/db+ mice (animals 1, 2, 8, and 13) and control db+/m+ or m+/m+ mice were equivalent at a target cell to spleen cell ratio of 1:8. The same four db+/db+ mice, however, demonstrated a slight but statistically significant (P < 0.05) decrease in percent 5tCr release at low target cell to spleen cell ratios (1:1 or 1:2). One of five db+/db+ mice (animal 7) demonstrated diminished cytolytic activity at all target cell to spleen cell ratios examined. When compared with the diminished cytolytic activity of db+/db+ spleen cells after in vivo immunization (Table IV) , the defect after in vitro immunization was distinctly less pronounced.
Allogeneic skin grafting (Table VI) . When full thickness skin grafts from allogeneic C57BL/6 (H-2b) mice were placed on db+/db+ (H-2d) hosts, the rejection time was significantly (P < 0.01) prolonged as compared with db+/m+ (H-2d) as hosts. The db+/m+ mice rejected C57BL/6 skin as well as did C57BL/KsJ (H-2d) hosts.
Weights and in vivo DNA synthesis of thymus and spleen (Table VII) . Both the spleen and thymus of db+/db+ mice weighed significantly less than organs from db+/m+ mice. Furthermore, in vivo DNA synthesis (as measured by [1251] UdR uptake) in the thymuses of the db+/db+ mice was markedly less than that found in the thymuses of db+/m+ mice. In contrast no differences were noted in [125 ] UdR uptake of spleens from db+/db+ mice (despite their smaller weights) and db+/m+ mice.
DISCUSSION
The present studies demonstrate a markedly altered in vivo immune response in obese, diabetic db+/db+ mice characterized by a significantly diminished ability to reject allogeneic full-thickness skin grafts, a markedly diminished capacity to generate cytotoxic The discrepancies observed between in vivo and in vitro immunological assays suggest that the alteration in in vivo immune function of db+/db+ mice may be a consequence of the abnormal metabolic environment present in these animals. Whether the defect in immune function is related to persistent hyperglycemia, to the hyperinsulinemia and decreased insulin receptor activity on lymphocytes (13) or monocytes (27) , to the metabolic consequences of obesity or to other metabolic factors is unknown; further work is needed to clarify this point. Pallavicini and Nichols (11) have described the existence of factor(s) in the plasma of alloxan-induced diabetic rats with suppressed in vitro blastogenic responses of both diabetic and normal rats. Thompson (28) has shown that in vivo administration of insulin can augment cell-mediated immune response to purified protein derivative in albino rats. An effect of insulin and glucose on the function of polymorphonuclear leukocytes of diabetic patients has been described (4, 5). Helderman and Strom (29) have reported that alloimmune T lymphocytes express insulin receptors and that brief (1-6 min) exposure of cytotoxic cells from nondiabetic rats to physiological concentration of insulin augments T-cell-mediated cytotoxicity (30) . If cytotoxic cells were preincubated with insulin (1-0.01 nNI) for a longer period of time (8 min (33) have demonstrated that the antibody responses to bovine serum albumini of alloxan-treated, hypoinsulinemic, hyperglycemic mice and normal controls are similar. We have documented an enhanced PFC response to in vivo immunization with SRBC in the spontaneous diabetic db+/db+ mouse. The reasons for this disparity are unknown but may reflect either differences in the in vivo metabolic environment in the experimental models or differences in the techniques used to evaluate humoral immutnity.
The depressed in vivo generation of killer cells and the delayed rejection of allogeneic skin grafts in db+/db+ mice suggests a significant in vivo defect in T-cell cytotoxic fuinictioni. The enhanced sheep erythrocyte PFC response in vivo in db+/db+ mice may be due to deficient T-regulatory or suppressor cell activity (34, 35) . Recently both cytotoxic and suppressor T cells have been shown to carry Ly 2 and Ly 3 surface markers (36 
